TITLE

HEALTHLINX CONFIRMS COLLABORATORS FOR OVPLEX OVARIAN CANCER

PUB. DATE
December 2009
SOURCE
Worldwide Biotech;Dec2009, Vol. 21 Issue 12, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the collaborators selected by HealthLinx Limited for its second larger OvPlex� ovarian cancer diagnostic trial. The countries where the trial will take place include Australia, Singapore and Great Britain. The study will focus on the detection of early stage symptomatic women. Some of the people who will work with HealthLinx on the trial include Professor Lewis Perrin, director of Gynaecological Oncology at Mater Hospital and Associate Professor Mahesh Choolani from the National University of Singapore.
ACCESSION #
45545717

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics